Platelet thromboxane release after subarachnoid hemorrhage and surgery

Area of Science:

• Neuroscience
• Hematology
• Vascular Biology

Background:

• Subarachnoid hemorrhage (SAH) is a critical neurological condition.
• Platelet function plays a role in cerebrovascular events.
• Understanding post-SAH hematologic changes is crucial for patient outcomes.

Purpose of the Study:

• To investigate adenosine diphosphate-induced platelet aggregation and thromboxane B2 release in patients with SAH.
• To assess changes in platelet function in the acute phase and after surgical intervention for SAH.
• To explore the potential link between platelet hyperaggregability and delayed ischemic deterioration.

Main Methods:

• Platelet-rich plasma from 88 SAH patients and 26 healthy controls was analyzed.
• Adenosine diphosphate-induced platelet aggregation was measured.
• Thromboxane B2 release was quantified.
• Platelet counts were monitored over time.

Main Results:

• SAH patients exhibited decreased platelet aggregability and thromboxane release in the first 3 days post-hemorrhage.
• These initial changes normalized within days.
• Surgery led to significant increases in platelet aggregability and thromboxane release (p < 0.05 and p < 0.001, respectively).
• Elevated thromboxane release was most pronounced in patients with delayed ischemic deterioration.

Conclusions:

• Platelet function is altered in the acute phase and post-surgery following subarachnoid hemorrhage.
• Postoperative platelet hyperaggregability may be associated with delayed ischemic complications.
• The precise role of these hematologic changes in the pathogenesis of delayed ischemic deterioration requires further investigation.